The new drug would add another oral GLP-1 with no fasting or fluid intake restrictions to clinicians’ toolboxes, improving options for targeted treatment.
Residency spots are more competitive than ever. Here, we look at the good and the bad of the specialties that are making waves.
The risk of some psoriasis-associated pathologies, such as cardiovascular disease, are better recognized than others.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results